» Articles » PMID: 17318262

Overexpression of Akt Converts Radial Growth Melanoma to Vertical Growth Melanoma

Abstract

Melanoma is the cancer with the highest increase in incidence, and transformation of radial growth to vertical growth (i.e., noninvasive to invasive) melanoma is required for invasive disease and metastasis. We have previously shown that p42/p44 MAP kinase is activated in radial growth melanoma, suggesting that further signaling events are required for vertical growth melanoma. The molecular events that accompany this transformation are not well understood. Akt, a signaling molecule downstream of PI3K, was introduced into the radial growth WM35 melanoma in order to test whether Akt overexpression is sufficient to accomplish this transformation. Overexpression of Akt led to upregulation of VEGF, increased production of superoxide ROS, and the switch to a more pronounced glycolytic metabolism. Subcutaneous implantation of WM35 cells overexpressing Akt led to rapidly growing tumors in vivo, while vector control cells did not form tumors. We demonstrated that Akt was associated with malignant transformation of melanoma through at least 2 mechanisms. First, Akt may stabilize cells with extensive mitochondrial DNA mutation, which can generate ROS. Second, Akt can induce expression of the ROS-generating enzyme NOX4. Akt thus serves as a molecular switch that increases angiogenesis and the generation of superoxide, fostering more aggressive tumor behavior. Targeting Akt and ROS may be of therapeutic importance in treatment of advanced melanoma.

Citing Articles

Current Insights into the Role of UV Radiation-Induced Oxidative Stress in Melanoma Pathogenesis.

Gieniusz E, Skrzydlewska E, Luczaj W Int J Mol Sci. 2024; 25(21).

PMID: 39519202 PMC: 11546485. DOI: 10.3390/ijms252111651.


Oxidative State in Cutaneous Melanoma Progression: A Question of Balance.

Benedusi M, Lee H, Lim Y, Valacchi G Antioxidants (Basel). 2024; 13(9).

PMID: 39334716 PMC: 11428248. DOI: 10.3390/antiox13091058.


Melanoma progression and prognostic models drawn from single-cell, spatial maps of benign and malignant tumors.

Love N, Williams C, Killingbeck E, Merleev A, Doost M, Yu L Sci Adv. 2024; 10(28):eadm8206.

PMID: 38996022 PMC: 11244543. DOI: 10.1126/sciadv.adm8206.


LPCAT1 promotes melanoma cell proliferation via Akt signaling.

Wang Y, Huang Y, Wang Y, Zhang W, Wang N, Bai R Oncol Rep. 2024; 51(5).

PMID: 38551165 PMC: 10995661. DOI: 10.3892/or.2024.8726.


The role of mitochondria in the resistance of melanoma to PD-1 inhibitors.

Du F, Yang L, Liu J, Wang J, Fan L, Duangmano S J Transl Med. 2023; 21(1):345.

PMID: 37221594 PMC: 10207731. DOI: 10.1186/s12967-023-04200-9.


References
1.
Yang J, Buettner G, Domann F, Li Q, Engelhardt J, Weydert C . v-Ha-ras mitogenic signaling through superoxide and derived reactive oxygen species. Mol Carcinog. 2002; 33(4):206-18. DOI: 10.1002/mc.10037. View

2.
Govindarajan B, Klafter R, Miller M, Mansur C, Mizesko M, Bai X . Reactive oxygen-induced carcinogenesis causes hypermethylation of p16(Ink4a) and activation of MAP kinase. Mol Med. 2002; 8(1):1-8. PMC: 2039931. View

3.
Brar S, Kennedy T, Sturrock A, Huecksteadt T, Quinn M, Whorton A . An NAD(P)H oxidase regulates growth and transcription in melanoma cells. Am J Physiol Cell Physiol. 2002; 282(6):C1212-24. DOI: 10.1152/ajpcell.00496.2001. View

4.
Archer H, Bar-Sagi D . Ras and Rac as activators of reactive oxygen species (ROS). Methods Mol Biol. 2002; 189:67-73. DOI: 10.1385/1-59259-281-3:067. View

5.
Irani K, Xia Y, Zweier J, Sollott S, Der C, Fearon E . Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science. 1997; 275(5306):1649-52. DOI: 10.1126/science.275.5306.1649. View